Hospital Mater Dei S.A (MATD3) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Hospital Mater Dei S.A (MATD3) has a cash flow conversion efficiency ratio of 0.094x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (R$137.68 Million ≈ $27.01 Million USD) by net assets (R$1.46 Billion ≈ $287.03 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Hospital Mater Dei S.A - Cash Flow Conversion Efficiency Trend (2017–2024)
This chart illustrates how Hospital Mater Dei S.A's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read MATD3 liabilities breakdown for a breakdown of total debt and financial obligations.
Hospital Mater Dei S.A Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Hospital Mater Dei S.A ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
J&V Energy Tech Co Ltd
TW:6869
|
0.024x |
|
Jouder Precision Industry Kunshan Co Ltd
SHE:300549
|
0.044x |
|
Tianjin Motimo Membrane Tech
SHE:300334
|
-0.028x |
|
Regal Asian Investments Ltd
AU:RG8
|
N/A |
|
Kolte - Patil Developers Limited
NSE:KOLTEPATIL
|
0.134x |
|
Metrogas SA
BA:METR
|
0.043x |
|
Singaraja Putra
JK:SINI
|
0.040x |
|
Tonnellerie Francois Freres SA
PA:TFF
|
0.064x |
Annual Cash Flow Conversion Efficiency for Hospital Mater Dei S.A (2017–2024)
The table below shows the annual cash flow conversion efficiency of Hospital Mater Dei S.A from 2017 to 2024. For the full company profile with market capitalisation and key ratios, see MATD3 market cap overview.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | R$1.48 Billion ≈ $289.70 Million |
R$132.43 Million ≈ $25.99 Million |
0.090x | +0.09% |
| 2023-12-31 | R$1.75 Billion ≈ $344.21 Million |
R$157.21 Million ≈ $30.85 Million |
0.090x | +334.85% |
| 2022-12-31 | R$1.62 Billion ≈ $317.38 Million |
R$-61.72 Million ≈ $-12.11 Million |
-0.038x | -140.84% |
| 2021-12-31 | R$1.64 Billion ≈ $321.74 Million |
R$153.21 Million ≈ $30.06 Million |
0.093x | -69.53% |
| 2020-12-31 | R$261.06 Million ≈ $51.22 Million |
R$80.06 Million ≈ $15.71 Million |
0.307x | +157.31% |
| 2019-12-31 | R$846.77 Million ≈ $166.15 Million |
R$100.92 Million ≈ $19.80 Million |
0.119x | -47.75% |
| 2018-12-31 | R$741.10 Million ≈ $145.42 Million |
R$169.06 Million ≈ $33.17 Million |
0.228x | -17.39% |
| 2017-12-31 | R$646.81 Million ≈ $126.92 Million |
R$178.62 Million ≈ $35.05 Million |
0.276x | -- |
About Hospital Mater Dei S.A
Hospital Mater Dei S.A. operates hospitals in Brazil. The company provides healthcare services, such as hospitalizations, surgeries, oncology, medical consultations, exams, and other services. It also engages in data and artificial intelligence business. The company was incorporated in 1973 and is headquartered in Belo Horizonte, Brazil. Hospital Mater Dei S.A. is a subsidiary of JSS Empreendimen… Read more